tirzepatide hair loss studies GLP-1 and Loss: Does Ozempic, Wegovy, or Cause Hair Loss? Mounjaro and Hair Loss: Does
Description
Eli Lillys (NYSE:LLY) tirzepatide achieved up to 15.7% weight loss in the SURMOUNT-2 study, sparking a potential tirzepatide versus semaglutide competition in the obesity and type 2 diabetes treatment markets

Tirzepatide dosage Tirzepatide dosage usually starts with 2.5 mg injected weekly

Nausea occurs in 44% of Semaglutide users and roughly 33% of Tirzepatide users at peak doses according to 2025 clinical data

Although retatrutide is showing promising results in clinical trials, it has not yet been FDA approved, so conclusions cant be made around it being the best weight loss solution

TRZ is contraindicated in patients with multiple endocrine neoplasia syndrome type 2 and medullary thyroid cancer (Krauss et al
